WELL:PA:PA-HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF - Accumulating EUR (EUR)

ETF | Others |

Last Closing

USD 6.4545

Change

+0.08 (+1.25)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.18 (+0.39%)

USD 55.57B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+2.40 (+0.46%)

USD 13.81B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.87 (+0.50%)

USD 12.91B
WRD:PA HSBC MSCI World UCITS ETF

+0.11 (+0.33%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-1.38 (-0.53%)

USD 9.42B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+1.15 (+0.26%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.75 (+0.22%)

USD 7.98B
HHH:PA HSBC S&P 500 UCITS ETF

+0.25 (+0.47%)

USD 7.67B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

+0.38 (+0.45%)

USD 5.54B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.29 (-3.81%)

USD 5.25B

ETFs Containing WELL:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.15% 57% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.15% 57% F 52% F
Trailing 12 Months  
Capital Gain -3.66% 11% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.66% 10% F 33% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.40% 15% F 33% F
Dividend Return -0.40% 14% F 32% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.75% 85% B 98% N/A
Risk Adjusted Return -6.95% 14% F 31% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.